Propylthiouracil-Induced Vasculitis With Alveolar Hemorrhage Confirmed by Clinical, Laboratory, Computed Tomography, and Bronchoscopy Findings: A Case Report and Literature Review.

Propylthiouracil-induced autoimmune disease.

The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.

Propylthiouracil-induced lupus-like or vasculitis syndrome.

Alveolar hemorrhage in vasculitis: primary and secondary.

Propylthiouracil-induced leucocytoclastic vasculitis with pulmonary hemorrhage treated with plasmapheresis.

Thionamide-induced vasculitis: a case of alveolar haemorrhage secondary to propylthiouracil.

A fatal case of propylthiouracil-induced ANCA-positive vasculitis.

Diffuse alveolar hemorrhage associated with antineutrophil cytoplasmic antibody levels in a pregnant woman taking propylthiouracil.

Propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.

Pulmonary capillaritis with hemorrhage due to propylthiouracil therapy in a child.

Antineutrophil cytoplasmic antibody positive alveolar haemorrhage during propylthiouracil therapy for hyperthyroidism.

Diffuse alveolar hemorrhage associated with myeloperoxidase-antineutrophil cytoplasmic antibody induced by propylthiouracil therapy.

Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil.

Propylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure.